| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 726146 | Null | 0.0295480456086947 | 0.37333353 |
| NSC 735403 | Null | 0.0295480456086947 | 0.44193818 |
| NSC 744989 | 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.0295480456086947 | 0.37869276 |
| NSC 746684 | 7-{[3-(dibutylamino)propyl]amino}-5-imino-1,3,6-triphenyl-5,6-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dithione | 0.0295480456086947 | 0.39330739 |
| NSC 113908 | Null | 0.0303322639291198 | 0.25098041 |
| NSC 627371 | 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- | 0.0303322639291198 | 0.38354214 |
| NSC 632877 | Dicarbonyl[1-(phenylazo)naphthaline-2-olato(O1,N1)]- iridium(I) | 0.0303322639291198 | 0.42551016 |
| NSC 639505 | Cyclopentanone, 2-[(4-morpholinyl)methyl]-5-nonylidene, hydrochloride | 0.0303322639291198 | 0.33540259 |
| NSC 639511 | Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride | 0.0303322639291198 | 0.35297735 |
| NSC 749505 | 3,4-diphenylisoxazolo[3,4-d]pyridazin-7(6H)-one | 0.0355196177493895 | 0.45005107 |